Atlas Trials

A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

Clinical trial NCT00412958 · COMPLETED

Trial details

NCT number
NCT00412958
Sponsor
ThromboGenics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vitrectomy
Start date
2006-12-01
Primary completion
2008-10-01
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.